Human Gene Therapy · 1991 · 127 citations · 11 references
MedicineGeneticsImmunologyCell TherapyClinical ImmunologyGene TherapyCellular TherapyCombined ImmunodeficiencyIn Vivo Gene TherapyAdenosine Deaminase DeficiencyAdenosine Deaminase TherapyCellular Gene TherapyGene Therapy For ImmunodeficiencyImmune Cell Gene EditingImmune Cell Gene ModificationT Cell-based Immunotherapy
Genetically corrected T cells are currently under investigation as a treatment for severe combined immunodeficiency disease resulting from a lack of adenosine deaminase (ADA). Monthly injections of these ADA-corrected T cells have resulted in measurable ADA activity in the peripheral blood and the in vivo production of antibody to blood group antigen. Genetically corrected T cells appear to be clinically valuable vehicles for gene therapy.
11
ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
E.R. Giblett, JeanneE. Anderson, Flossie Cohen et al. · The Lancet · 1972 · 1.7K citations
Yael Levy, Michael S. Hershfield, Cristina Fernández‐Mejía et al. · The Journal of Pediatrics · 1988 · 214 citations